Form 4: MCB Director Sells Shares Under 10b5-1 Plan

Metropolitan Bank Holding Corp. Director Robert C. Patent sold 5,000 shares of common stock for approximately $79.02 per share.

Summary

• Director Robert C. Patent of Metropolitan Bank Holding Corp. sold 5,000 shares of common stock.
• The transaction occurred on August 27, 2025, and was executed under a Rule 10b5-1 trading plan.
• The shares were sold at a weighted average price of $79.0194, with individual transaction prices ranging from $78.7400 to $79.2237.
• Following the sale, Mr. Patent directly owns 98,685 shares, which includes restricted stock units scheduled to vest on January 27, 2026.
• Mr. Patent also indirectly holds 32,882 shares through a sibling (beneficial ownership disclaimed) and 14,445 shares through a profit-sharing plan.

Sentiment

Score: 5

Explanation: A director sale, even under a 10b5-1 plan, is generally neutral to slightly negative, but the amount is not exceptionally large relative to total holdings, and the pre-planned nature mitigates strong negative sentiment.

Positives

• The sale was conducted under a Rule 10b5-1 plan, indicating it was pre-scheduled and not necessarily a reaction to new, negative information.

Negatives

• A director selling shares can sometimes be interpreted as a slight negative signal regarding their outlook on the company's short-term prospects, although the 10b5-1 plan mitigates this.

Future Outlook

The filing does not provide specific forward-looking statements or guidance regarding the company's future performance.

Management Comments

• The Reporting Person undertakes to provide to Metropolitan Bank Holding Corp., any security holder of Metropolitan Bank Holding Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote 1.
• The Reporting Person disclaims beneficial ownership of these securities [held by sibling], and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction and does not provide information to analyze broader industry trends or competitor actions.

Comparison to Industry Standards

• This filing is a standard insider transaction disclosure and does not contain information for comparison to industry-specific financial benchmarks or project results.

Stakeholder Impact

• Shareholders: The sale by a director could be perceived as a minor signal, but the 10b5-1 plan suggests it is not based on new, undisclosed information.

Next Steps

• Restricted stock units held by the director are scheduled to vest on January 27, 2026.

Key Dates

Recommendation

This Form 4 reports a routine insider sale by a director under a pre-arranged 10b5-1 plan. While insider sales can sometimes be a negative signal, the pre-planned nature and the relatively small size of the transaction (5,000 shares) do not suggest a fundamental change in the company's prospects or warrant a change in investment thesis based solely on this filing. Investors should continue to hold and monitor broader company performance and market conditions.

Keywords

Metropolitan Bank Holding Corp., MCB, Insider Trading, Form 4, Director Sale, Robert C. Patent, 10b5-1 Plan, Equity Transaction